Skip to main content
HQY logo

HQY · Healthequity, Inc. · Documents

Track HQY — free
Market Cap
$8.56B
Shares
82.72M
Volume · Nov 16 234.01K Avg daily vol (3M) 867.78K

The company's filings, earnings calls and investor events, most recent first. Search and read these filings from Claude or ChatGPT with the SEC filings MCP server →

Annual report FY2026 Revenue $1.31B up 9.5% 10-K filed Mar 17, 2026 Quarterly report FY2027 Q2 Revenue $350.73M up 7.6% 10-Q filed Aug 27, 2026 Latest results Financial results 8-K filed Aug 27, 2026 Earnings call Q2 2027 earnings call Held Aug 27, 2026
2026
Oct 9
Current report 8-K Events of Oct 5
Director or officer change, or executive pay

HealthEquity, Inc. terminated Michael Fiore as Chief Commercial Officer without cause, effective October 5, 2026, and will redistribute his responsibilities among other members of its management team.

Aug 27
Quarterly report 10-Q FY2027 Q2, ended Jul 31
Quarterly report for FY2027 Q2 AI summary on its way
Revenue $350.73M ▲ 7.6% Net income $65.64M ▲ 9.7% Diluted EPS $0.78 ▲ 14.7%
May 28
Quarterly report 10-Q FY2027 Q1, ended Apr 30
Quarterly report for FY2027 Q1 AI summary on its way
Revenue $354.64M ▲ 7.2% Net income $69.42M ▲ 28.8% Diluted EPS $0.82 ▲ 34.4%
Mar 17
Annual report 10-K FY2026, ended Jan 31
Annual report for FY2026 AI summary on its way
Revenue $1.31B ▲ 9.5% Net income $215.2M ▲ 122.5% Diluted EPS $2.46 ▲ 125.7%
2025
Dec 3
Quarterly report 10-Q FY2026 Q3, ended Oct 31
Quarterly report for FY2026 Q3
Revenue $322.16M ▲ 7.2% Net income $51.69M ▲ 806.4% Diluted EPS $0.59 ▲ 883.3%
Sep 2
Quarterly report 10-Q FY2026 Q2, ended Jul 31
Quarterly report for FY2026 Q2
Revenue $325.84M ▲ 8.6% Net income $59.85M ▲ 67.1% Diluted EPS $0.68 ▲ 70.0%
Jun 3
Quarterly report 10-Q FY2026 Q1, ended Apr 30
Quarterly report for FY2026 Q1
Revenue $330.84M ▲ 15.0% Net income $53.92M ▲ 87.1% Diluted EPS $0.61 ▲ 84.8%
Mar 18
Annual report 10-K FY2025, ended Jan 31
Annual report for FY2025
Revenue $1.2B ▲ 20.0% Net income $96.7M ▲ 73.6% Diluted EPS $1.09 ▲ 70.3%
2024
Dec 9
Quarterly report 10-Q FY2025 Q3, ended Oct 31
Quarterly report for FY2025 Q3
Revenue $300.43M ▲ 20.5% Net income $5.7M ▼ 61.1% Diluted EPS $0.06 ▼ 64.7%
Sep 3
Quarterly report 10-Q FY2025 Q2, ended Jul 31
Quarterly report for FY2025 Q2
Revenue $299.93M ▲ 23.1% Net income $35.82M ▲ 238.6% Diluted EPS $0.40 ▲ 233.3%
Showing 1–50 of 176 documents
Key facts CIK 1428336 CUSIP 42226A107 13F (30d) 418 filings 380 filers Visit website Investor relations